EGFR and neoplasm: Compared with traditional drug delivery systems, the MPEG-PLA nanoparticles co-encapsulating EGFR drugs and integrin αvβ3 inhibitor had an average size of 25 nm with a high stability and low clearance rate, which was preferred by tumor tissues due to the EPR effects and selected release of drugs induced by environment pH.